 "Intra-day trading strategies from Geojit BNP Paribas")
ADANI PORTS AND SEZ (Rs 200.35)
Support at Rs 195 below Rs 193.50. Resistance is at Rs 203.70 above Rs 208. (Buy for intraday with a stoploss below Rs 193.50)
[STOCHASTICS BUY + VOLUME JUMP + ABV PREVIOUS CLOSE]
BHEL (Rs 103.25)
Support at Rs 101.10 below Rs 99.90. Resistance is at Rs 105 above Rs 107.50. (Sell for intraday with a stoploss above Rs 107.50)
AUROBINDO PHARMA (Rs 629.15)
Support at Rs 621 below Rs 618.30. Resistance is at Rs 636 above Rs 641. (Sell for intraday with a stoploss above Rs 641)
[MACD SELL+ BELOW PREVIOUS CLOSE+ RISE IN VOLUME + BELOW MOVING AVERAGES]
PVR (Rs 733.45)
Support at Rs 728.50 below Rs 721.90. Resistance is at Rs 742 above Rs 749.60. (Buy for intraday with a stoploss below Rs 721.90)
[VOLUME JUMP + ABV PREVIOUS CLOSE + STOCHASTICS BUY]
KESORAM INDUSTRIES (Rs 81.90)
Support at Rs 80.70 below Rs 80.10. Resistance is at Rs 82.60 above Rs 85 (Buy for intraday with a stoploss below Rs 80.10)
[MACD & STOCHASTICS BUY+ VOLUME JUMP + ABV PREVIOUS CLOSE]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.
Support at Rs 195 below Rs 193.50. Resistance is at Rs 203.70 above Rs 208. (Buy for intraday with a stoploss below Rs 193.50)
[STOCHASTICS BUY + VOLUME JUMP + ABV PREVIOUS CLOSE]
BHEL (Rs 103.25)
Support at Rs 101.10 below Rs 99.90. Resistance is at Rs 105 above Rs 107.50. (Sell for intraday with a stoploss above Rs 107.50)
More From This Section
[VOLUME JUMP+ BELOW MOVING AVERAGES + MACD & STOCHASTICS SELL + NEW LOW]
AUROBINDO PHARMA (Rs 629.15)
Support at Rs 621 below Rs 618.30. Resistance is at Rs 636 above Rs 641. (Sell for intraday with a stoploss above Rs 641)
[MACD SELL+ BELOW PREVIOUS CLOSE+ RISE IN VOLUME + BELOW MOVING AVERAGES]
PVR (Rs 733.45)
Support at Rs 728.50 below Rs 721.90. Resistance is at Rs 742 above Rs 749.60. (Buy for intraday with a stoploss below Rs 721.90)
[VOLUME JUMP + ABV PREVIOUS CLOSE + STOCHASTICS BUY]
KESORAM INDUSTRIES (Rs 81.90)
Support at Rs 80.70 below Rs 80.10. Resistance is at Rs 82.60 above Rs 85 (Buy for intraday with a stoploss below Rs 80.10)
[MACD & STOCHASTICS BUY+ VOLUME JUMP + ABV PREVIOUS CLOSE]
Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.